| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | Codexis Inc Com | 10,000 | 39,000 | 0.00% | ||
| 2 | VERASTEM INC | 10,900 | 82,000 | 0.00% | ||
| 3 | RAPTOR PHARMACEUTICAL CORP | 16,000 | 253,000 | 0.01% | ||
| 4 | XOMA CORP DEL | 152,200 | 591,000 | 0.03% | ||
| 5 | MEDIDATA SOLUTIONS INC | 18,900 | 1,027,000 | 0.06% | ||
| 6 | FEI COMPANY | 14,800 | 1,227,000 | 0.07% | ||
| 7 | INFINITY PHARMACEUTICALS INC | 112,600 | 1,233,000 | 0.07% | ||
| 8 | INCONTACT INC | 150,000 | 1,481,000 | 0.08% | ||
| 9 | TANDEM DIABETES CARE INC COM | 155,300 | 1,683,000 | 0.09% | ||
| 10 | CIDARA THERAPEUTICS INC | 122,628 | 1,719,000 | 0.09% | ||
| 11 | REGULUS THERAPEUTICS INC COM | 160,516 | 1,759,000 | 0.10% | ||
| 12 | ATHENA HEALTH INC. | 16,300 | 1,868,000 | 0.10% | ||
| 13 | ONCOMED PHARMACEUTICALS INC COM | 85,100 | 1,915,000 | 0.10% | ||
| 14 | IMMUNE DESIGN CORP | 102,904 | 2,125,000 | 0.11% | ||
| 15 | INSMED INC | 88,600 | 2,164,000 | 0.12% | ||
| 16 | SPARK THERAPEUTICS INCORPORATED | 38,200 | 2,302,000 | 0.12% | ||
| 17 | UNIQURE NV | 90,500 | 2,444,000 | 0.13% | ||
| 18 | ACCURAY INCORPORATED COM | 364,600 | 2,457,000 | 0.13% | ||
| 19 | CARDIOVASCULAR SYS INC DEL COM | 103,700 | 2,743,000 | 0.15% | ||
| 20 | ACCELERON PHARMA INC | 87,100 | 2,756,000 | 0.15% | ||
| 21 | SAGE THERAPEUTICS INC | 40,200 | 2,935,000 | 0.16% | ||
| 22 | APPLIED GENETIC TECHNOL CORP | 205,500 | 3,152,000 | 0.17% | ||
| 23 | Esperion Therapeutics Inc | 39,000 | 3,189,000 | 0.17% | ||
| 24 | NATUS MEDICAL INC. | 75,000 | 3,192,000 | 0.17% | ||
| 25 | ATRICURE INC | 152,300 | 3,753,000 | 0.20% | ||
| 26 | ASPEN TECHNOLOGY COM USD0.10 | 83,000 | 3,781,000 | 0.20% | ||
| 27 | DBV TECHNOLOGIES S A | 128,400 | 3,824,000 | 0.21% | ||
| 28 | DICERNA PHARMACEUTICALS INC | 275,300 | 3,840,000 | 0.21% | ||
| 29 | REPLIGEN CORP COM | 99,400 | 4,102,000 | 0.22% | ||
| 30 | LOXO ONCOLOGY INC COM | 243,700 | 4,394,000 | 0.24% | ||
| 31 | GW PHARMACEUTICALS PLC | 36,100 | 4,435,000 | 0.24% | ||
| 32 | CASTLIGHT HEALTH INC COM CL B | 550,600 | 4,482,000 | 0.24% | ||
| 33 | TG THERAPEUTICS INC COM | 271,100 | 4,498,000 | 0.24% | ||
| 34 | CERNER CORP | 65,300 | 4,510,000 | 0.24% | ||
| 35 | DYNAVAX TECHNOLOGIES CORP | 194,500 | 4,556,000 | 0.25% | ||
| 36 | SUPERNUS PHARMACEUTICALS INC | 286,600 | 4,866,000 | 0.26% | ||
| 37 | CEMPRA INC | 153,800 | 5,285,000 | 0.29% | ||
| 38 | SANGAMO THERAPEUTICS INCORPORATED | 482,500 | 5,351,000 | 0.29% | ||
| 39 | ALNYLAM PHARMACEUTICALS INC | 45,500 | 5,454,000 | 0.30% | ||
| 40 | RETROPHIN INC | 165,100 | 5,473,000 | 0.30% | ||
| 41 | SEATTLE GENETICS INC | 128,100 | 6,200,000 | 0.34% | ||
| 42 | ZOSANO PHARMA CORP | 878,400 | 6,368,000 | 0.34% | ||
| 43 | COSTAMARE INC | 360,200 | 6,617,000 | 0.36% | ||
| 44 | QUANTA SVCS INC | 232,800 | 6,709,000 | 0.36% | ||
| 45 | TESARO INCORPORATED | 115,400 | 6,784,000 | 0.37% | ||
| 46 | BIOMARIN PHARMACEUTICAL INC | 51,800 | 7,085,000 | 0.38% | ||
| 47 | XENCOR INC COM | 327,700 | 7,200,000 | 0.39% | ||
| 48 | NEUROCRINE BIOSCIE COM USD0.001 | 151,400 | 7,231,000 | 0.39% | ||
| 49 | CELLDEX THERAPEUTICS INC NEW | 288,700 | 7,281,000 | 0.39% | ||
| 50 | SAREPTA THERAPEUTICS INC | 259,100 | 7,884,000 | 0.43% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001442891-15-000006, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
